Virology. 2010 May 25;401(1):18-28. doi: 10.1016/j.virol.2010.02.015. Epub 2010 Mar 3. Ebola virus uses clathrin-mediated endocytosis as an entry pathway.
Tiivistelmä. Abstract
Ebola virus (EBOV)
infects several cell types and while viral entry is known to be
pH-dependent, the exact entry pathway(s) remains unknown. To gain
insights into EBOV entry, the role of several inhibitors of clathrin-mediated endocytosis in blocking infection mediated by HIV pseudotyped with the EBOV
envelope glycoprotein (EbGP) was examined. Wild type HIV and
envelope-minus HIV pseudotyped with Vesicular Stomatitis Virus
glycoprotein (VSVg) were used as controls to assess cell viability after
inhibiting clathrin pathway. Inhibition of clathrin pathway using dominant-negative Eps15, siRNA-mediated knockdown of clathrin
heavy chain, chlorpromazine and sucrose blocked EbGP pseudotyped HIV
infection. Also, both chlorpromazine and Bafilomycin A1 inhibited entry
of infectious EBOV. Sensitivity of EbGP pseudotyped HIV as well as infectious EBOV to inhibitors of clathrin suggests that EBOV uses clathrin-mediated endocytosis as an entry pathway. Furthermore, since chlorpromazine inhibits EBOV infection, novel therapeutic modalities could be designed based on this lead compound.
- PMID:
- 20202662
- [PubMed - indexed for MEDLINE]
- PMCID:
- PMC3732189
Lisäys: klorpromazine on vahva antihistamiini, mikä vaikutus myös on ebolan vastainen. Lisäksi se on hibernoiva, laskee lämpötilaa, mikä on aivostoa suojaava. Jokin toinenkin neuroleptika on antihistamiini Nozinan.
Inga kommentarer:
Skicka en kommentar